Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet. 2007 May 12;369(9573):1621-6 Authors: Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To [...]
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med. 2007 May 15;146(10):707-13 Authors: Ahmad J, Bryce CL, Cacciarelli T, Roberts MS BACKGROUND: The Model for End-Stage Liver Disease (MELD) score has been used since February 2002 to allocate livers for transplantation from deceased donors according to medical [...]
Hypopituitarism. Lancet. 2007 Apr 28;369(9571):1461-70 Authors: Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E Incidence and prevalence of hypopituitarism are estimated to be 4.2 per 100,000 per year and 45.5 per 100,000, respectively. Although the clinical symptoms of this disorder are usually unspecific, it can cause life-threatening events and lead to increased mortality. [...]
Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007 May 9;297(18):1985-91 Authors: Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, Dubach P, Resink TJ, Pfisterer M CONTEXT: The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients [...]
